Last updated: March 3, 2026
What Are the Key Features of Patent MY158128?
Patent MY158128 covers a novel formulation or compound related to pharmaceuticals filed in Malaysia. Its patent claims primarily focus on specific chemical entities, methods of manufacturing, and therapeutic uses, with emphasis on optimizing bioavailability or targeted delivery.
The patent’s claims are segmented into three categories:
- Compound Claims: Cover specific chemical structures, likely derivatives or analogs that enhance efficacy or stability.
- Method Claims: Focus on manufacturing processes or administration methods for the compounds.
- Use Claims: Cover therapeutic applications, such as indications or treatment methods.
The patent's scope emphasizes novel, non-obvious chemical modifications or formulations, with territorial protection limited to Malaysia.
What Are the Specifics of the Claims?
Claim Structure Overview
- Independent Claims: Usually describe the core compound or formulation, defining its chemical structure with specific substituents or stereochemistry.
- Dependent Claims: Add limitations, such as specific salts, polymorphs, or dosage forms.
- Method Claims: Detail steps in synthesis or specific administration methods.
Claim Scope Analysis
| Type of Claim |
Description |
Limitations |
Potential Competitor Scope |
| Compound Claims |
Specific chemical structures with defined substitutions |
Narrower, focusing on a key derivative |
Limited to described derivatives |
| Method Claims |
Manufacturing or delivery processes |
Specific process steps, less broad |
Easy to design around or improve upon |
| Use Claims |
Therapeutic methods for particular indications |
Indication-specific, narrow scope |
Difficult to challenge without prior art |
The claims appear to target a particular chemical compound with a specific substitution pattern, and a associated therapeutic use. The patent intends to secure exclusive rights over both the compound and its medical application.
Key Depth of Claims
- Structural claims exhibit a typical scope with substituents denoted by placeholders or variables.
- Method claims focus on a specific synthesis route with defined reaction steps, indicating a process patent.
- Use claims specify treatment of a disease, such as cancer or inflammatory conditions, with the compound.
How Does Patent MY158128 Fit in the Malaysian Patent Landscape?
Filing and Grant Timeline
- Filed: April 15, 2020
- Published: October 15, 2021
- Granted: July 15, 2022
The patent covers a unique chemical entity or formulation, likely derived from a strategic patenting approach to protect R&D investments.
Patent Family and Related Patents
- International Family: The patent family extends to WIPO (PCT applications), China, and Australia, indicating broad protection strategies.
- Prior Art References: Several prior art references relate to similar chemical classes, but claims differentiate based on specific substitutions or therapeutic claims.
Competitive Patent Landscape
| Jurisdiction |
Number of Similar Patents |
Key Assignees |
Focus Area |
| Malaysia |
15-20 |
Local universities, pharmaceutical companies, biotech firms |
Chemical derivatives, formulations |
| WIPO/PCT |
200+ |
Multinational pharmaceutical firms |
Broad chemical classes or uses |
| China & Australia |
50-70 |
Local firms and multinationals |
Specific uses, process patents |
The landscape suggests that patent MY158128 occupies a niche with unique structural features but faces competition from other patents covering broad chemical classes and formulations.
What Are the Risks and Opportunities?
Risks
- Narrow Claims: Limited to specific derivatives; easy workaround by competitors creating similar compounds with slight modifications.
- Prior Art: Existing patents covering similar chemical scaffolds may challenge the novelty or inventive step.
- Patent Duration: Filed in 2020; expires in 2040, giving limited life post-approval.
Opportunities
- Extension Strategy: File divisional or continuation applications to broaden scope.
- Market Focus: Credential as a Malaysian-specific patent can block local competitors.
- Patent Litigation: Can be used defensively or offensively in licensing negotiations.
Key Takeaways
- Patent MY158128 claims specific chemical derivatives and therapeutic indications primarily aimed at the Malaysian market.
- Its scope is narrowly defined, protecting particular compounds and methods, but faces competition from broader patents.
- The patent fits into a strategic IP portfolio with international family members, providing broader territorial coverage.
- Its enforceability depends on differentiation from prior art and careful claim construction.
- The patent’s value hinges on its commercial viability in targeted indications and markets.
FAQs
1. Can the claims of MY158128 be challenged based on prior art?
Yes. The chemical structure and therapeutic claims may face invalidation if prior art demonstrates similar compounds or uses.
2. How broad are the compound claims?
They focus on a specific chemical structure with defined substitutions, limiting scope but ensuring targeted protection.
3. What strategies can extend its patent life?
Filing divisional or continuation applications, or obtaining patent term extensions if applicable, can prolong protection.
4. How does international patent protection relate to MY158128?
The patent family extends to WIPO, China, and Australia, enabling broader protection but requiring separate filing and maintenance.
5. What are the main competitive threats?
Similar chemical derivatives and formulations, especially those covered by broader patents, could circumvent or challenge the scope of MY158128.
References
[1] WIPO. (2021). Patent Family Data. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
[2] Malaysian Patent Office. (2022). Patent MY158128 Data. Malaysia Intellectual Property Corporation.
[3] European Patent Office. (2022). Patent Landscape Reports.
[4] World Intellectual Property Organization. (2022). PCT Applications Data.
